Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HRSA rebate dispute resolution rules drop requirement for audit plan pre-approval.

Executive Summary

HRSA Rx REBATE DISPUTE RESOLUTION RULE DROPS AUDIT PLAN APPROVAL REQUIREMENT, according to a Dec. 12 Federal Register notice announcing the Health Resources & Services Administration's final guidelines on audits and dispute resolution for prescription drug rebates paid to HHS under the Veterans Health Care Act of 1992. In response to a comment on the draft guidelines announced in June 1994, the "requirement for approval of an audit plan has been dropped," the notice states.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel